Biological E expects to launch COVID vaccine Corbevax by September end: Sources
Advertisement
New Delhi: The Hyderabad-based pharmaceutical company Biological E is expected to launch its COVID-19 vaccine Corbevax by September end in India, said sources on Monday.
Sources told ANI that the company has started its phase 3 clinical trials.
Biological E's COVID-19 vaccine Corbevax has been booked by the government before preclinical stage phase 3 studies.
In the latest written reply, Union Minister of State for Health, Dr Bharati Pravin Pawar said that the Government of India has also provided financial assistance to domestic vaccine manufacturer Biological E which is currently in advance phase 3 clinical trials for 'at-risk manufacturing' of the COVID-19 vaccine.
Biological E is expected to apply for an Emergency use License (EUL) by August end and will be supplying 300 million doses to the Government of India by December 2021.
This comes a day after an expert panel has recommended the government to increase the vaccination and stick to non-pharmacological interventions, in a bid to curtail a possible third wave of COVID-19 as speculated by many health experts and COVID management bodies which might hit the country by September.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.